These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10569200)

  • 1. A light, rather than a heavy solution for hard working hearts.
    Luft FC
    J Mol Med (Berl); 1999 Sep; 77(9):631-3. PubMed ID: 10569200
    [No Abstract]   [Full Text] [Related]  

  • 2. A gradient of myosin regulatory light-chain phosphorylation across the ventricular wall supports cardiac torsion.
    Davis JS; Hassanzadeh S; Winitsky S; Wen H; Aletras A; Epstein ND
    Cold Spring Harb Symp Quant Biol; 2002; 67():345-52. PubMed ID: 12858559
    [No Abstract]   [Full Text] [Related]  

  • 3. Too light to be essential? Insights from FHC-related mutations in essential myosin light chains.
    Krüger M
    Cardiovasc Res; 2012 Mar; 93(3):381-2. PubMed ID: 22266750
    [No Abstract]   [Full Text] [Related]  

  • 4. Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
    Yuan CC; Muthu P; Kazmierczak K; Liang J; Huang W; Irving TC; Kanashiro-Takeuchi RM; Hare JM; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4138-46. PubMed ID: 26124132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy.
    Redwood CS; Moolman-Smook JC; Watkins H
    Cardiovasc Res; 1999 Oct; 44(1):20-36. PubMed ID: 10615387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The R21C Mutation in Cardiac Troponin I Imposes Differences in Contractile Force Generation between the Left and Right Ventricles of Knock-In Mice.
    Liang J; Kazmierczak K; Rojas AI; Wang Y; Szczesna-Cordary D
    Biomed Res Int; 2015; 2015():742536. PubMed ID: 25961037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of ventricular essential myosin light chain disturb myosin binding and sarcomeric sorting.
    Lossie J; Ushakov DS; Ferenczi MA; Werner S; Keller S; Haase H; Morano I
    Cardiovasc Res; 2012 Mar; 93(3):390-6. PubMed ID: 22131351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct sequences and post-translational modifications in cardiac atrial and ventricular myosin light chains revealed by top-down mass spectrometry.
    Gregorich ZR; Cai W; Lin Z; Chen AJ; Peng Y; Kohmoto T; Ge Y
    J Mol Cell Cardiol; 2017 Jun; 107():13-21. PubMed ID: 28427997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different expressivity of a ventricular essential myosin light chain gene Ala57Gly mutation in familial hypertrophic cardiomyopathy.
    Lee W; Hwang TH; Kimura A; Park SW; Satoh M; Nishi H; Harada H; Toyama J; Park JE
    Am Heart J; 2001 Feb; 141(2):184-9. PubMed ID: 11174330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of myosin light chain phosphorylation on length-dependent myosin kinetics in skinned rat myocardium.
    Pulcastro HC; Awinda PO; Breithaupt JJ; Tanner BC
    Arch Biochem Biophys; 2016 Jul; 601():56-68. PubMed ID: 26763941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myosin light chain phosphorylation to the rescue.
    Granzier HL; de Tombe PP
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9148-9. PubMed ID: 26157138
    [No Abstract]   [Full Text] [Related]  

  • 12. The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.
    Sorajja P; Elliott PM; McKenna WJ
    Europace; 2000 Jan; 2(1):4-14. PubMed ID: 11225594
    [No Abstract]   [Full Text] [Related]  

  • 13. Human cardiac myosin light chain 4 (MYL4) mosaic expression patterns vary by sex.
    Wang TY; Arking DE; Maleszewski JJ; Fox-Talbot K; Nieuwenhuis TO; Santhanam L; Virmani R; Rosenberg AZ; Halushka MK
    Sci Rep; 2019 Sep; 9(1):12681. PubMed ID: 31481666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified
    Yuan CC; Kazmierczak K; Liang J; Zhou Z; Yadav S; Gomes AV; Irving TC; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2338-E2347. PubMed ID: 29463717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myosin binding protein-C: enigmatic regulator of cardiac contraction.
    Oakley CE; Chamoun J; Brown LJ; Hambly BD
    Int J Biochem Cell Biol; 2007; 39(12):2161-6. PubMed ID: 17320463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulating the contractile apparatus: genetically defined animal models of cardiovascular disease.
    Dalloz F; Osinska H; Robbins J
    J Mol Cell Cardiol; 2001 Jan; 33(1):9-25. PubMed ID: 11133219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuning the human heart molecular motors by myosin light chains.
    Morano I
    J Mol Med (Berl); 1999 Jul; 77(7):544-55. PubMed ID: 10494800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic rabbits expressing mutant essential light chain do not develop hypertrophic cardiomyopathy.
    James J; Zhang Y; Wright K; Witt S; Glascock E; Osinska H; Klevitsky R; Martin L; Yager K; Sanbe A; Robbins J
    J Mol Cell Cardiol; 2002 Jul; 34(7):873-82. PubMed ID: 12099725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of atrial myosin light chains but not alpha-myosin heavy chains is correlated in vivo with increased ventricular function in patients with hypertrophic obstructive cardiomyopathy.
    Ritter O; Luther HP; Haase H; Baltas LG; Baumann G; Schulte HD; Morano I
    J Mol Med (Berl); 1999 Sep; 77(9):677-85. PubMed ID: 10569205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy: a case study in converging pathways.
    Robbins J
    J Clin Invest; 1996 Dec; 98(11):2433-4. PubMed ID: 8958201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.